Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (16453)	3/4/1998 6:04:00 PM
From: Torben Noerup Nielsen	Respond to of 32384

Henry, >That's a lot of first and by definition, is not history repeating. I'm sorry I did not make myself clear. I wasn't talking about LGND's history, but about the history of the silly bickering on the thread :-) You are absolutely right regarding LGND itself. It has made some substantial strides. By the way, an assessment was made by one of the analysts - I forget which - to the effect that LGND's fair value was $18 at the beginning of this year and would be $25 by the end of the year. That was before the rat breast cancer results too. Anyone care to speculate what fair value is now? While I am sure we would all like to see LGND at $30 tomorrow, I don't think that is very realistic :-) The real question is what a realistic value is for now. I fully expect some substantial up and down fluctuations around a moving mean (hopefully a monotone increasing one :-)). Thanks, Torben